Latest Bmy News and Updates : Bmy updates, Bmy News , Bmy around the world

Nishadil

Washington | 20°C (heavy intensity rain)

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

Top story

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

In focus

Latest feed

Unlocking Faster Drug Production: FDA Launches 'Precheck' for New Pharma Plants

The Enduring Allure of Dividend Growers: Champions, Contenders, and Challengers

Bristol Myers Squibb: Navigating the Patent Storm, Still a Cash Machine?

The Closing Bell: Unpacking Our Final Trades for a Volatile Market

Latest headlines

Bristol Myers Squibb: A Cautious Optimism Amidst Looming Headwinds

Bristol Myers Squibb: A Cautious Optimism Amidst Looming Headwinds

The Surprising Calm: Why Healthcare ETFs Aren't Rattled by Pharma Price Cuts

The Surprising Calm: Why Healthcare ETFs Aren't Rattled by Pharma Price Cuts

A New Beacon of Hope: Bristol Myers Squibb's Breyanzi Achieves Fifth FDA Approval

A New Beacon of Hope: Bristol Myers Squibb's Breyanzi Achieves Fifth FDA Approval

CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future

CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future

The CAR-T Paradox: Why Arcellx Shares Tumbled Despite 100% Response Rate

The CAR-T Paradox: Why Arcellx Shares Tumbled Despite 100% Response Rate

A Fresh Look at Regeneron: Why Analysts Are Seeing Significant Upside

A Fresh Look at Regeneron: Why Analysts Are Seeing Significant Upside

Beyond the Old Playbook: Crafting a Resilient Portfolio for Today's Unpredictable Markets

Beyond the Old Playbook: Crafting a Resilient Portfolio for Today's Unpredictable Markets

Navigating the Nuances of Cytokinetics: December's Catalyst and the Investment Conundrum

Navigating the Nuances of Cytokinetics: December's Catalyst and the Investment Conundrum

Texas Attorney General Takes On Pharma Giants Sanofi and Bristol Myers Squibb Over Alleged Plavix Warning Failures

Texas Attorney General Takes On Pharma Giants Sanofi and Bristol Myers Squibb Over Alleged Plavix Warning Failures

Unlocking Value in Healthcare: A Prudent Path to S&P 500 Dividends

Unlocking Value in Healthcare: A Prudent Path to S&P 500 Dividends

A Seismic Shift? Unpacking RFK Jr.'s Radical Vision for America's Top Health Regulator

A Seismic Shift? Unpacking RFK Jr.'s Radical Vision for America's Top Health Regulator

The Great Economic Puzzle: Is America Really Heading for a Downturn?

The Great Economic Puzzle: Is America Really Heading for a Downturn?

The Rocket Ride: How Intensity Therapeutics Ignited Wall Street (and Hope) with its Cancer Breakthrough

The Rocket Ride: How Intensity Therapeutics Ignited Wall Street (and Hope) with its Cancer Breakthrough

The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market

The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope

Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Unearthing Hidden Gems: The Top 30 Most Undervalued S&P 500 Stocks for Astute Investors

Unearthing Hidden Gems: The Top 30 Most Undervalued S&P 500 Stocks for Astute Investors

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Empowering Patients: Bristol-Myers Squibb Unveils Enhanced Digital Support for Opdivo

Empowering Patients: Bristol-Myers Squibb Unveils Enhanced Digital Support for Opdivo

Unlocking Hidden Value: Why Bristol Myers Squibb is a Deep Bargain Poised for a Rebound

Unlocking Hidden Value: Why Bristol Myers Squibb is a Deep Bargain Poised for a Rebound

Controversial Critic Returns: Dr. Vinay Prasad Reassumes Key FDA Role

Controversial Critic Returns: Dr. Vinay Prasad Reassumes Key FDA Role

Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave

Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave

The Generative AI Illusion: Consulting Firms Struggle to Deliver on Lofty Promises

The Generative AI Illusion: Consulting Firms Struggle to Deliver on Lofty Promises

Bristol-Myers Squibb: An Unmissable Opportunity Before the Market Corrects Its Oversight

Bristol-Myers Squibb: An Unmissable Opportunity Before the Market Corrects Its Oversight

A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress

A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress

Load more